Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
( 26 27 26 27 I-clinical_variable
ANC 27 30 27 30 I-clinical_variable
) 30 31 30 31 I-clinical_variable
> 32 33 32 33 O
= 33 34 33 34 O
1,500 35 40 35 40 B-lower_bound
/ 40 41 40 41 I-lower_bound
mcL 41 44 41 44 I-lower_bound

Alanine 0 7 45 52 B-clinical_variable
aminotransferase 8 24 53 69 I-clinical_variable
( 25 26 70 71 I-clinical_variable
ALT 26 29 71 74 I-clinical_variable
) 29 30 74 75 I-clinical_variable
and 31 34 76 79 I-clinical_variable
aspartate 35 44 80 89 I-clinical_variable
aminotransferase 45 61 90 106 I-clinical_variable
( 62 63 107 108 I-clinical_variable
AST 63 66 108 111 I-clinical_variable
) 66 67 111 112 I-clinical_variable
= 68 69 113 114 O
< 69 70 114 115 O
2.5 71 74 116 119 B-upper_bound
x 75 76 120 121 I-upper_bound
ULN 77 80 122 125 I-upper_bound
or 81 83 126 128 O
= 84 85 129 130 O
< 85 86 130 131 O
5 87 88 132 133 O
x 89 90 134 135 O
ULN 91 94 136 139 O
for 95 98 140 143 O
subjects 99 107 144 152 O
with 108 112 153 157 O
liver 113 118 158 163 B-cancer
metastases 119 129 164 174 I-cancer

Creatinine 0 10 175 185 B-clinical_variable
levels 11 17 186 192 I-clinical_variable
< 18 19 193 194 O
1.5 20 23 195 198 B-upper_bound
x 24 25 199 200 I-upper_bound
upper 26 31 201 206 I-upper_bound
limit 32 37 207 212 I-upper_bound
of 38 40 213 215 I-upper_bound
normal 41 47 216 222 I-upper_bound
( 48 49 223 224 I-upper_bound
ULN 49 52 224 227 I-upper_bound
) 52 53 227 228 I-upper_bound

Has 0 3 229 232 O
a 4 5 233 234 O
diagnosis 6 15 235 244 O
of 16 18 245 247 O
immunodeficiency 19 35 248 264 B-chronic_disease
or 36 38 265 267 O
is 39 41 268 270 O
receiving 42 51 271 280 O
systemic 52 60 281 289 B-treatment
steroid 61 68 290 297 I-treatment
therapy 69 76 298 305 I-treatment
or 77 79 306 308 O
any 80 83 309 312 O
other 84 89 313 318 O
form 90 94 319 323 O
of 95 97 324 326 O
immunosuppressive 98 115 327 344 B-treatment
therapy 116 123 345 352 I-treatment

Has 0 3 353 356 O
a 4 5 357 358 O
history 6 13 359 366 O
of 14 16 367 369 O
( 17 18 370 371 O
non 18 21 371 374 O
- 21 22 374 375 O
infectious 22 32 375 385 O
) 32 33 385 386 O
pneumonitis 34 45 387 398 B-chronic_disease
that 46 50 399 403 O
required 51 59 404 412 O
steroids 60 68 413 421 B-treatment
or 69 71 422 424 O
current 72 79 425 432 O
pneumonitis 80 91 433 444 O

Has 0 3 445 448 O
a 4 5 449 450 O
known 6 11 451 456 O
active 12 18 457 463 O
hepatitis 19 28 464 473 B-chronic_disease
B 29 30 474 475 I-chronic_disease
or 31 33 476 478 O
hepatitis 34 43 479 488 B-chronic_disease
C 44 45 489 490 I-chronic_disease

Has 0 3 491 494 O
a 4 5 495 496 O
known 6 11 497 502 O
history 12 19 503 510 O
of 20 22 511 513 O
human 23 28 514 519 B-chronic_disease
immunodeficiency 29 45 520 536 I-chronic_disease
virus 46 51 537 542 I-chronic_disease
( 52 53 543 544 I-chronic_disease
HIV 53 56 544 547 I-chronic_disease
) 56 57 547 548 I-chronic_disease

Has 0 3 549 552 O
a 4 5 553 554 O
known 6 11 555 560 O
malignancy 12 22 561 571 B-cancer
( 23 24 572 573 O
other 24 29 573 578 O
than 30 34 579 583 O
breast 35 41 584 590 B-cancer
cancer 42 48 591 597 I-cancer
) 48 49 597 598 O
except 50 56 599 605 O
basal 57 62 606 611 B-cancer
cell 63 67 612 616 I-cancer
carcinoma 68 77 617 626 I-cancer
or 78 80 627 629 O
squamous 81 89 630 638 B-cancer
cell 90 94 639 643 I-cancer
carcinoma 95 104 644 653 I-cancer
of 105 107 654 656 I-cancer
the 108 111 657 660 I-cancer
skin 112 116 661 665 I-cancer
, 116 117 665 666 O
or 118 120 667 669 O
in 121 123 670 672 O
situ 124 128 673 677 O
cervical 129 137 678 686 B-cancer
cancer 138 144 687 693 I-cancer
that 145 149 694 698 O
has 150 153 699 702 O
undergone 154 163 703 712 O
potentially 164 175 713 724 O
curative 176 184 725 733 B-treatment
therapy 185 192 734 741 I-treatment

Has 0 3 742 745 O
a 4 5 746 747 O
performance 6 17 748 759 B-clinical_variable
status 18 24 760 766 I-clinical_variable
of 25 27 767 769 O
0 28 29 770 771 B-lower_bound
- 29 30 771 772 O
1 30 31 772 773 B-upper_bound
on 32 34 774 776 O
the 35 38 777 780 O
Eastern 39 46 781 788 B-clinical_variable
Cooperative 47 58 789 800 I-clinical_variable
Oncology 59 67 801 809 I-clinical_variable
Group 68 73 810 815 I-clinical_variable
( 74 75 816 817 I-clinical_variable
ECOG 75 79 817 821 I-clinical_variable
) 79 80 821 822 I-clinical_variable
performance 81 92 823 834 I-clinical_variable
scale 93 98 835 840 I-clinical_variable

Has 0 3 841 844 O
an 4 6 845 847 O
active 7 13 848 854 O
autoimmune 14 24 855 865 B-chronic_disease
disease 25 32 866 873 I-chronic_disease
requiring 33 42 874 883 O
systemic 43 51 884 892 B-treatment
treatment 52 61 893 902 I-treatment
within 62 68 903 909 O
the 69 72 910 913 O
past 73 77 914 918 B-upper_bound
3 78 79 919 920 I-upper_bound
months 80 86 921 927 I-upper_bound
or 87 89 928 930 O
a 90 91 931 932 O
documented 92 102 933 943 O
history 103 110 944 951 O
of 111 113 952 954 O
clinically 114 124 955 965 O
severe 125 131 966 972 O
autoimmune 132 142 973 983 O
disease 143 150 984 991 O
, 150 151 991 992 O
or 152 154 993 995 O
a 155 156 996 997 O
syndrome 157 165 998 1006 O
that 166 170 1007 1011 O
requires 171 179 1012 1020 O
systemic 180 188 1021 1029 B-treatment
steroids 189 197 1030 1038 I-treatment
or 198 200 1039 1041 O
immunosuppressive 201 218 1042 1059 B-treatment
agents 219 225 1060 1066 I-treatment
; 225 226 1066 1067 O
subjects 227 235 1068 1076 O
with 236 240 1077 1081 O
vitiligo 241 249 1082 1090 B-chronic_disease
or 250 252 1091 1093 O
resolved 253 261 1094 1102 O
childhood 262 271 1103 1112 O
asthma 272 278 1113 1119 B-chronic_disease
/ 278 279 1119 1120 I-chronic_disease
atopy 279 284 1120 1125 I-chronic_disease
would 285 290 1126 1131 O
be 291 293 1132 1134 O
an 294 296 1135 1137 O
exception 297 306 1138 1147 O
to 307 309 1148 1150 O
this 310 314 1151 1155 O
rule 315 319 1156 1160 O
; 319 320 1160 1161 O
subjects 321 329 1162 1170 O
that 330 334 1171 1175 O
require 335 342 1176 1183 O
intermittent 343 355 1184 1196 O
use 356 359 1197 1200 O
of 360 362 1201 1203 O
bronchodilators 363 378 1204 1219 B-treatment
or 379 381 1220 1222 O
local 382 387 1223 1228 B-treatment
steroid 388 395 1229 1236 I-treatment
injections 396 406 1237 1247 I-treatment
would 407 412 1248 1253 O
not 413 416 1254 1257 O
be 417 419 1258 1260 O
excluded 420 428 1261 1269 O
from 429 433 1270 1274 O
the 434 437 1275 1278 O
study 438 443 1279 1284 O
; 443 444 1284 1285 O
subjects 445 453 1286 1294 O
with 454 458 1295 1299 O
hypothyroidism 459 473 1300 1314 B-chronic_disease
stable 474 480 1315 1321 O
on 481 483 1322 1324 O
hormone 484 491 1325 1332 B-treatment
replacement 492 503 1333 1344 I-treatment
or 504 506 1345 1347 O
Sjogren 507 514 1348 1355 B-chronic_disease
's 514 516 1355 1357 I-chronic_disease
syndrome 517 525 1358 1366 I-chronic_disease
will 526 530 1367 1371 O
not 531 534 1372 1375 O
be 535 537 1376 1378 O
excluded 538 546 1379 1387 O
from 547 551 1388 1392 O
the 552 555 1393 1396 O
study 556 561 1397 1402 O

Has 0 3 1403 1406 O
an 4 6 1407 1409 O
active 7 13 1410 1416 B-chronic_disease
infection 14 23 1417 1426 I-chronic_disease
requiring 24 33 1427 1436 O
systemic 34 42 1437 1445 B-treatment
therapy 43 50 1446 1453 I-treatment

Has 0 3 1454 1457 O
clinical 4 12 1458 1466 O
response 13 21 1467 1475 O
or 22 24 1476 1478 O
stable 25 31 1479 1485 O
disease 32 39 1486 1493 O
for 40 43 1494 1497 O
minimum 44 51 1498 1505 O
of 52 54 1506 1508 O
two 55 58 1509 1512 B-lower_bound
months 59 65 1513 1519 I-lower_bound
( 66 67 1520 1521 O
three 67 72 1521 1526 O
cycles 73 79 1527 1533 O
of 80 82 1534 1536 O
every 83 88 1537 1542 O
three 89 94 1543 1548 O
week 95 99 1549 1553 O
chemotherapy 100 112 1554 1566 B-treatment
or 113 115 1567 1569 O
8 116 117 1570 1571 B-upper_bound
weeks 118 123 1572 1577 I-upper_bound
of 124 126 1578 1580 O
weekly 127 133 1581 1587 O
regimen 134 141 1588 1595 O
, 141 142 1595 1596 O
etc 143 146 1597 1600 O
. 146 147 1600 1601 O
) 147 148 1601 1602 O
after 149 154 1603 1608 O
receiving 155 164 1609 1618 O
any 165 168 1619 1622 O
prior 169 174 1623 1628 B-treatment
chemotherapy 175 187 1629 1641 I-treatment
for 188 191 1642 1645 O
metastatic 192 202 1646 1656 B-cancer
/ 202 203 1656 1657 I-cancer
recurrent 203 212 1657 1666 I-cancer
disease 213 220 1667 1674 I-cancer
; 220 221 1674 1675 O
a 222 223 1676 1677 O
minimum 224 231 1678 1685 O
of 232 234 1686 1688 O
two 235 238 1689 1692 B-lower_bound
cycles 239 245 1693 1699 I-lower_bound
( 246 247 1700 1701 O
6 247 248 1701 1702 B-lower_bound
- 248 249 1702 1703 O
8 249 250 1703 1704 O
weeks 251 256 1705 1710 O
) 256 257 1710 1711 O
of 258 260 1712 1714 O
chemotherapy 261 273 1715 1727 O
is 274 276 1728 1730 O
required 277 285 1731 1739 O
to 286 288 1740 1742 O
determine 289 298 1743 1752 O
clinical 299 307 1753 1761 O
response 308 316 1762 1770 O
; 316 317 1770 1771 O
per 318 321 1772 1775 O
Response 322 330 1776 1784 O
Evaluation 331 341 1785 1795 O
Criteria 342 350 1796 1804 O
in 351 353 1805 1807 O
Solid 354 359 1808 1813 O
Tumors 360 366 1814 1820 O
( 367 368 1821 1822 O
RECIST 368 374 1822 1828 O
) 374 375 1828 1829 O
criteria 376 384 1830 1838 O
1.1 385 388 1839 1842 O
, 388 389 1842 1843 O
clinical 390 398 1844 1852 O
response 399 407 1853 1861 O
for 408 411 1862 1865 O
measurable 412 422 1866 1876 O
disease 423 430 1877 1884 O
is 431 433 1885 1887 O
defined 434 441 1888 1895 O
as 442 444 1896 1898 O
complete 445 453 1899 1907 O
response 454 462 1908 1916 O
( 463 464 1917 1918 O
CR 464 466 1918 1920 O
) 466 467 1920 1921 O
or 468 470 1922 1924 O
partial 471 478 1925 1932 O
response 479 487 1933 1941 O
( 488 489 1942 1943 O
PR 489 491 1943 1945 O
) 491 492 1945 1946 O
; 492 493 1946 1947 O
for 494 497 1948 1951 O
non 498 501 1952 1955 O
- 501 502 1955 1956 O
measurable 502 512 1956 1966 O
disease 513 520 1967 1974 O
only 521 525 1975 1979 O
( 526 527 1980 1981 O
i.e. 527 531 1981 1985 O
bone 532 536 1986 1990 B-cancer
metastasis 537 547 1991 2001 I-cancer
, 547 548 2001 2002 O
ascites 549 556 2003 2010 B-chronic_disease
, 556 557 2010 2011 O
pleural 558 565 2012 2019 B-chronic_disease
effusion 566 574 2020 2028 I-chronic_disease
, 574 575 2028 2029 O
and 576 579 2030 2033 O
pathological 580 592 2034 2046 B-clinical_variable
lymph 593 598 2047 2052 I-clinical_variable
nodes 599 604 2053 2058 I-clinical_variable
> 605 606 2059 2060 O
= 606 607 2060 2061 O
10 608 610 2062 2064 B-lower_bound
to 611 613 2065 2067 O
< 614 615 2068 2069 O
15 616 618 2070 2072 B-upper_bound
mm 619 621 2073 2075 I-upper_bound
short 622 627 2076 2081 I-upper_bound
axis 628 632 2082 2086 I-upper_bound
) 632 633 2086 2087 O
is 634 636 2088 2090 O
defined 637 644 2091 2098 O
as 645 647 2099 2101 O
persistence 648 659 2102 2113 O
of 660 662 2114 2116 O
one 663 666 2117 2120 O
or 667 669 2121 2123 O
more 670 674 2124 2128 O
non 675 678 2129 2132 O
- 678 679 2132 2133 O
target 679 685 2133 2139 O
lesion(s 686 694 2140 2148 O
) 694 695 2148 2149 O
and 696 699 2150 2153 O
no 700 702 2154 2156 O
increase 703 711 2157 2165 O
in 712 714 2166 2168 O
overall 715 722 2169 2176 O
tumor 723 728 2177 2182 B-cancer
burden 729 735 2183 2189 O

Has 0 3 2190 2193 O
histological 4 16 2194 2206 O
confirmation 17 29 2207 2219 O
of 30 32 2220 2222 O
HER2 33 37 2223 2227 B-cancer
normal 38 44 2228 2234 I-cancer
breast 45 51 2235 2241 I-cancer
carcinoma 52 61 2242 2251 I-cancer
with 62 66 2252 2256 O
a 67 68 2257 2258 O
clinical 69 77 2259 2267 O
diagnosis 78 87 2268 2277 O
of 88 90 2278 2280 O
IBC 91 94 2281 2284 B-cancer
based 95 100 2285 2290 O
on 101 103 2291 2293 O
presence 104 112 2294 2302 O
of 113 115 2303 2305 O
inflammatory 116 128 2306 2318 O
changes 129 136 2319 2326 O
in 137 139 2327 2329 O
the 140 143 2330 2333 O
involved 144 152 2334 2342 O
breast 153 159 2343 2349 O
, 159 160 2349 2350 O
including 161 170 2351 2360 O
diffuse 171 178 2361 2368 O
erythema 179 187 2369 2377 B-chronic_disease
and 188 191 2378 2381 O
edema 192 197 2382 2387 B-chronic_disease
( 198 199 2388 2389 O
peau 199 203 2389 2393 B-chronic_disease
d'orange 204 212 2394 2402 I-chronic_disease
) 212 213 2402 2403 O
, 213 214 2403 2404 O
with 215 219 2405 2409 O
or 220 222 2410 2412 O
without 223 230 2413 2420 O
an 231 233 2421 2423 O
underlying 234 244 2424 2434 O
palpable 245 253 2435 2443 O
mass 254 258 2444 2448 O
involving 259 268 2449 2458 O
the 269 272 2459 2462 O
majority 273 281 2463 2471 O
of 282 284 2472 2474 O
the 285 288 2475 2478 O
skin 289 293 2479 2483 O
of 294 296 2484 2486 O
the 297 300 2487 2490 O
breast 301 307 2491 2497 O
; 307 308 2497 2498 O
pathological 309 321 2499 2511 O
evidence 322 330 2512 2520 O
of 331 333 2521 2523 O
dermal 334 340 2524 2530 B-cancer
lymphatic 341 350 2531 2540 I-cancer
invasion 351 359 2541 2549 I-cancer
should 360 366 2550 2556 O
be 367 369 2557 2559 O
noted 370 375 2560 2565 O
but 376 379 2566 2569 O
is 380 382 2570 2572 O
not 383 386 2573 2576 O
required 387 395 2577 2585 O
for 396 399 2586 2589 O
diagnosis 400 409 2590 2599 O
of 410 412 2600 2602 O
inflammatory 413 425 2603 2615 B-cancer
breast 426 432 2616 2622 I-cancer
cancer 433 439 2623 2629 I-cancer
regardless 440 450 2630 2640 O
estrogen 451 459 2641 2649 O
receptor 460 468 2650 2658 O
( 469 470 2659 2660 O
ER)/progesterone 470 486 2660 2676 O
receptor 487 495 2677 2685 O
( 496 497 2686 2687 O
PR 497 499 2687 2689 O
) 499 500 2689 2690 O
status 501 507 2691 2697 O
; 507 508 2697 2698 O
OR 509 511 2699 2701 O
has 512 515 2702 2705 O
histological 516 528 2706 2718 O
confirmation 529 541 2719 2731 O
of 542 544 2732 2734 O
triple 545 551 2735 2741 B-cancer
negative 552 560 2742 2750 I-cancer
breast 561 567 2751 2757 I-cancer
carcinoma 568 577 2758 2767 I-cancer
( 578 579 2768 2769 O
HER2 579 583 2769 2773 O
normal 584 590 2774 2780 O
, 590 591 2780 2781 O
ER 592 594 2782 2784 B-clinical_variable
/ 594 595 2784 2785 I-clinical_variable
PR 595 597 2785 2787 I-clinical_variable
< 598 599 2788 2789 O
10 600 602 2790 2792 B-upper_bound
% 602 603 2792 2793 I-upper_bound
) 603 604 2793 2794 O
without 605 612 2795 2802 O
clinical 613 621 2803 2811 O
diagnosis 622 631 2812 2821 O
of 632 634 2822 2824 O
IBC 635 638 2825 2828 O

Has 0 3 2829 2832 O
known 4 9 2833 2838 O
active 10 16 2839 2845 O
central 17 24 2846 2853 B-cancer
nervous 25 32 2854 2861 I-cancer
system 33 39 2862 2868 I-cancer
( 40 41 2869 2870 I-cancer
CNS 41 44 2870 2873 I-cancer
) 44 45 2873 2874 I-cancer
metastases 46 56 2875 2885 I-cancer
and/or 57 63 2886 2892 O
carcinomatous 64 77 2893 2906 B-cancer
meningitis 78 88 2907 2917 I-cancer
; 88 89 2917 2918 O
subjects 90 98 2919 2927 O
with 99 103 2928 2932 O
previously 104 114 2933 2943 O
treated 115 122 2944 2951 O
brain 123 128 2952 2957 B-cancer
metastases 129 139 2958 2968 I-cancer
may 140 143 2969 2972 O
participate 144 155 2973 2984 O
if 156 158 2985 2987 O
they 159 163 2988 2992 O
are 164 167 2993 2996 O
stable 168 174 2997 3003 O
, 174 175 3003 3004 O
and 176 179 3005 3008 O
have 180 184 3009 3013 O
no 185 187 3014 3016 O
evidence 188 196 3017 3025 O
of 197 199 3026 3028 O
new 200 203 3029 3032 O
or 204 206 3033 3035 O
enlarging 207 216 3036 3045 O
brain 217 222 3046 3051 O
metastases 223 233 3052 3062 O
, 233 234 3062 3063 O
and 235 238 3064 3067 O
are 239 242 3068 3071 O
not 243 246 3072 3075 O
using 247 252 3076 3081 O
steroids 253 261 3082 3090 B-treatment
for 262 265 3091 3094 O
at 266 268 3095 3097 O
least 269 274 3098 3103 O
7 275 276 3104 3105 B-lower_bound
days 277 281 3106 3110 I-lower_bound
prior 282 287 3111 3116 I-lower_bound
to 288 290 3117 3119 O
trial 291 296 3120 3125 O
treatment 297 306 3126 3135 B-treatment

Has 0 3 3136 3139 O
known 4 9 3140 3145 O
psychiatric 10 21 3146 3157 B-chronic_disease
or 22 24 3158 3160 O
substance 25 34 3161 3170 O
abuse 35 40 3171 3176 O
disorders 41 50 3177 3186 O
that 51 55 3187 3191 O
would 56 61 3192 3197 O
interfere 62 71 3198 3207 O
with 72 76 3208 3212 O
cooperation 77 88 3213 3224 O
with 89 93 3225 3229 O
the 94 97 3230 3233 O
requirements 98 110 3234 3246 O
of 111 113 3247 3249 O
the 114 117 3250 3253 O
trial 118 123 3254 3259 O

Has 0 3 3260 3263 O
negative 4 12 3264 3272 B-pregnancy
serum 13 18 3273 3278 I-pregnancy
or 19 21 3279 3281 O
urine 22 27 3282 3287 B-pregnancy
pregnancy 28 37 3288 3297 I-pregnancy
test 38 42 3298 3302 O
for 43 46 3303 3306 O
subjects 47 55 3307 3315 O
of 56 58 3316 3318 O
childbearing 59 71 3319 3331 O
potential 72 81 3332 3341 O

Has 0 3 3342 3345 O
not 4 7 3346 3349 O
recovered 8 17 3350 3359 O
from 18 22 3360 3364 O
adverse 23 30 3365 3372 O
events 31 37 3373 3379 O
due 38 41 3380 3383 O
to 42 44 3384 3386 O
prior 45 50 3387 3392 B-treatment
therapies 51 60 3393 3402 I-treatment
, 60 61 3402 3403 O
i.e. 62 66 3404 3408 O
monoclonal 67 77 3409 3419 B-treatment
antibody 78 86 3420 3428 I-treatment
, 86 87 3428 3429 O
chemotherapy 88 100 3430 3442 B-treatment
, 100 101 3442 3443 O
targeted 102 110 3444 3452 B-treatment
small 111 116 3453 3458 I-treatment
molecule 117 125 3459 3467 I-treatment
therapy 126 133 3468 3475 I-treatment
, 133 134 3475 3476 O
radiation 135 144 3477 3486 B-treatment
therapy 145 152 3487 3494 I-treatment
, 152 153 3494 3495 O
or 154 156 3496 3498 O
surgery 157 164 3499 3506 B-treatment
; 164 165 3506 3507 O
( 166 167 3508 3509 O
Note 167 171 3509 3513 O
: 171 172 3513 3514 O
subjects 173 181 3515 3523 O
with 182 186 3524 3528 O
grade 187 192 3529 3534 O
2 193 194 3535 3536 O
neuropathy 195 205 3537 3547 O
, 205 206 3547 3548 O
alopecia 207 215 3549 3557 B-chronic_disease
and 216 219 3558 3561 O
general 220 227 3562 3569 O
disorders 228 237 3570 3579 O
and 238 241 3580 3583 O
administration 242 256 3584 3598 O
site 257 261 3599 3603 O
conditions 262 272 3604 3614 O
[ 273 274 3615 3616 O
per 274 277 3616 3619 O
Common 278 284 3620 3626 O
Terminology 285 296 3627 3638 O
Criteria 297 305 3639 3647 O
for 306 309 3648 3651 O
Adverse 310 317 3652 3659 O
Events 318 324 3660 3666 O
( 325 326 3667 3668 O
CTCAE 326 331 3668 3673 O
) 331 332 3673 3674 O
version 333 340 3675 3682 O
4.0 341 344 3683 3686 O
] 344 345 3686 3687 O
are 346 349 3688 3691 O
an 350 352 3692 3694 O
exception 353 362 3695 3704 O
to 363 365 3705 3707 O
this 366 370 3708 3712 O
criterion 371 380 3713 3722 O
and 381 384 3723 3726 O
may 385 388 3727 3730 O
qualify 389 396 3731 3738 O
for 397 400 3739 3742 O
the 401 404 3743 3746 O
study 405 410 3747 3752 O
) 410 411 3752 3753 O

Has 0 3 3754 3757 O
received 4 12 3758 3766 O
prior 13 18 3767 3772 B-treatment
therapy 19 26 3773 3780 I-treatment
with 27 31 3781 3785 I-treatment
PD-1 32 36 3786 3790 I-treatment
, 36 37 3790 3791 O
anti 38 42 3792 3796 B-treatment
- 42 43 3796 3797 I-treatment
PD 43 45 3797 3799 I-treatment
- 45 46 3799 3800 I-treatment
L1 46 48 3800 3802 I-treatment
, 48 49 3802 3803 O
anti 50 54 3804 3808 B-treatment
- 54 55 3808 3809 I-treatment
PD 55 57 3809 3811 I-treatment
- 57 58 3811 3812 I-treatment
L2 58 60 3812 3814 I-treatment
, 60 61 3814 3815 O
anti 62 66 3816 3820 B-treatment
- 66 67 3820 3821 I-treatment
CD137 67 72 3821 3826 I-treatment
, 72 73 3826 3827 O
or 74 76 3828 3830 O
anti 77 81 3831 3835 B-treatment
- 81 82 3835 3836 I-treatment
cytotoxic 82 91 3836 3845 I-treatment
T 92 93 3846 3847 I-treatment
- 93 94 3847 3848 I-treatment
lymphocyte 94 104 3848 3858 I-treatment
- 104 105 3858 3859 I-treatment
associated 105 115 3859 3869 I-treatment
antigen-4 116 125 3870 3879 I-treatment
( 126 127 3880 3881 I-treatment
CTLA-4 127 133 3881 3887 I-treatment
) 133 134 3887 3888 I-treatment
antibody 135 143 3889 3897 I-treatment
( 144 145 3898 3899 O
including 145 154 3899 3908 O
ipilimumab 155 165 3909 3919 B-treatment
or 166 168 3920 3922 O
any 169 172 3923 3926 O
other 173 178 3927 3932 O
antibody 179 187 3933 3941 O
or 188 190 3942 3944 O
drug 191 195 3945 3949 O
specifically 196 208 3950 3962 O
targeting 209 218 3963 3972 O
T 219 220 3973 3974 O
- 220 221 3974 3975 O
cell 221 225 3975 3979 O
co 226 228 3980 3982 O
- 228 229 3982 3983 O
stimulation 229 240 3983 3994 O
or 241 243 3995 3997 O
checkpoint 244 254 3998 4008 O
pathways 255 263 4009 4017 O
) 263 264 4017 4018 O
within 265 271 4019 4025 O
3 272 273 4026 4027 B-treatment
months 274 280 4028 4034 I-treatment

Has 0 3 4035 4038 O
stage 4 9 4039 4044 B-upper_bound
IV 10 12 4045 4047 I-upper_bound
or 13 15 4048 4050 O
recurrent 16 25 4051 4060 O
disease 26 33 4061 4068 O
that 34 38 4069 4073 O
has 39 42 4074 4077 O
been 43 47 4078 4082 O
treated 48 55 4083 4090 O

Have 0 4 4091 4095 O
received 5 13 4096 4104 O
a 14 15 4105 4106 O
live 16 20 4107 4111 B-treatment
vaccine 21 28 4112 4119 I-treatment
within 29 35 4120 4126 O
30 36 38 4127 4129 B-upper_bound
days 39 43 4130 4134 I-upper_bound
prior 44 49 4135 4140 I-upper_bound
to 50 52 4141 4143 O
the 53 56 4144 4147 O
first 57 62 4148 4153 O
dose 63 67 4154 4158 O
of 68 70 4159 4161 O
trial 71 76 4162 4167 B-treatment
treatment 77 86 4168 4177 I-treatment

Hemoglobin 0 10 4178 4188 B-clinical_variable
( 11 12 4189 4190 I-clinical_variable
Hgb 12 15 4190 4193 I-clinical_variable
) 15 16 4193 4194 I-clinical_variable
> 17 18 4195 4196 O
= 18 19 4196 4197 O
9 20 21 4198 4199 B-lower_bound
g 22 23 4200 4201 I-lower_bound
/ 23 24 4201 4202 I-lower_bound
dL 24 26 4202 4204 I-lower_bound

Intrauterine 0 12 4205 4217 B-contraception_consent
devices 13 20 4218 4225 I-contraception_consent
( 21 22 4226 4227 I-contraception_consent
IUDs 22 26 4227 4231 I-contraception_consent
) 26 27 4231 4232 I-contraception_consent

Is 0 2 4233 4235 O
HER2 3 7 4236 4240 O
normal 8 14 4241 4247 O
, 14 15 4247 4248 O
defined 16 23 4249 4256 O
as 24 26 4257 4259 O
HER2 27 31 4260 4264 O
0 32 33 4265 4266 O
or 34 36 4267 4269 O
1 37 38 4270 4271 O
+ 38 39 4271 4272 O
by 40 42 4273 4275 O
immunohistochemistry 43 63 4276 4296 B-treatment
( 64 65 4297 4298 I-treatment
IHC 65 68 4298 4301 I-treatment
) 68 69 4301 4302 I-treatment
and 70 73 4303 4306 O
negative 74 82 4307 4315 O
by 83 85 4316 4318 O
fluorescence 86 98 4319 4331 B-treatment
in 99 101 4332 4334 I-treatment
situ 102 106 4335 4339 I-treatment
hybridization 107 120 4340 4353 I-treatment
( 121 122 4354 4355 I-treatment
FISH 122 126 4355 4359 I-treatment
) 126 127 4359 4360 I-treatment
if 128 130 4361 4363 O
performed 131 140 4364 4373 O
; 140 141 4373 4374 O
or 142 144 4375 4377 O
HER2 145 149 4378 4382 O
is 150 152 4383 4385 O
2 153 154 4386 4387 O
+ 154 155 4387 4388 O
by 156 158 4389 4391 O
IHC 159 162 4392 4395 O
and 163 166 4396 4399 O
negative 167 175 4400 4408 O
by 176 178 4409 4411 O
FISH 179 183 4412 4416 O
; 183 184 4416 4417 O
or 185 187 4418 4420 O
HER2 188 192 4421 4425 B-cancer
negative 193 201 4426 4434 I-cancer
by 202 204 4435 4437 O
FISH 205 209 4438 4442 O
if 210 212 4443 4445 O
IHC 213 216 4446 4449 O
is 217 219 4450 4452 O
not 220 223 4453 4456 O
performed 224 233 4457 4466 O

Is 0 2 4467 4469 O
currently 3 12 4470 4479 O
participating 13 26 4480 4493 O
in 27 29 4494 4496 O
a 30 31 4497 4498 O
study 32 37 4499 4504 O
of 38 40 4505 4507 O
an 41 43 4508 4510 O
investigational 44 59 4511 4526 B-treatment
anti 60 64 4527 4531 I-treatment
- 64 65 4531 4532 I-treatment
cancer 65 71 4532 4538 I-treatment
agent 72 77 4539 4544 I-treatment

Is 0 2 4545 4547 O
receiving 3 12 4548 4557 O
concurrent 13 23 4558 4568 O
anti 24 28 4569 4573 B-treatment
- 28 29 4573 4574 I-treatment
cancer 29 35 4574 4580 I-treatment
therapy 36 43 4581 4588 I-treatment
for 44 47 4589 4592 O
metastatic 48 58 4593 4603 B-cancer
disease 59 66 4604 4611 I-cancer

Platelets 0 9 4612 4621 B-clinical_variable
> 10 11 4622 4623 O
= 11 12 4623 4624 O
100,000 13 20 4625 4632 B-lower_bound
/mcL 21 25 4633 4637 I-lower_bound

Subjects 0 8 4638 4646 O
of 9 11 4647 4649 O
childbearing 12 24 4650 4662 O
potential 25 34 4663 4672 O
should 35 41 4673 4679 O
be 42 44 4680 4682 O
willing 45 52 4683 4690 B-contraception_consent
to 53 55 4691 4693 I-contraception_consent
use 56 59 4694 4697 I-contraception_consent
effective 60 69 4698 4707 I-contraception_consent
methods 70 77 4708 4715 I-contraception_consent
of 78 80 4716 4718 I-contraception_consent
birth 81 86 4719 4724 I-contraception_consent
control 87 94 4725 4732 I-contraception_consent
or 95 97 4733 4735 O
be 98 100 4736 4738 O
surgically 101 111 4739 4749 O
sterile 112 119 4750 4757 O
, 119 120 4757 4758 O
or 121 123 4759 4761 O
abstain 124 131 4762 4769 O
from 132 136 4770 4774 O
heterosexual 137 149 4775 4787 O
activity 150 158 4788 4796 O
for 159 162 4797 4800 O
the 163 166 4801 4804 O
course 167 173 4805 4811 O
of 174 176 4812 4814 O
the 177 180 4815 4818 O
study 181 186 4819 4824 O
through 187 194 4825 4832 O
at 195 197 4833 4835 O
least 198 203 4836 4841 O
4 204 205 4842 4843 B-lower_bound
months 206 212 4844 4850 I-lower_bound
after 213 218 4851 4856 I-lower_bound
the 219 222 4857 4860 O
last 223 227 4861 4865 O
dose 228 232 4866 4870 O
of 233 235 4871 4873 O
study 236 241 4874 4879 B-treatment
drug 242 246 4880 4884 I-treatment
; 246 247 4884 4885 O
subjects 248 256 4886 4894 O
of 257 259 4895 4897 O
childbearing 260 272 4898 4910 O
potential 273 282 4911 4920 O
are 283 286 4921 4924 O
those 287 292 4925 4930 O
who 293 296 4931 4934 O
have 297 301 4935 4939 O
not 302 305 4940 4943 O
been 306 310 4944 4948 O
surgically 311 321 4949 4959 O
sterilized 322 332 4960 4970 O
or 333 335 4971 4973 O
have 336 340 4974 4978 O
not 341 344 4979 4982 O
been 345 349 4983 4987 O
free 350 354 4988 4992 O
from 355 359 4993 4997 O
menses 360 366 4998 5004 O
for 367 370 5005 5008 O
> 371 372 5009 5010 O
1 373 374 5011 5012 B-lower_bound
year 375 379 5013 5017 I-lower_bound

Total 0 5 5018 5023 B-clinical_variable
bilirubin 6 15 5024 5033 I-clinical_variable
= 16 17 5034 5035 O
< 17 18 5035 5036 O
1.5 19 22 5037 5040 B-upper_bound
x 23 24 5041 5042 I-upper_bound
ULN 25 28 5043 5046 I-upper_bound

Use 0 3 5047 5050 B-contraception_consent
of 4 6 5051 5053 I-contraception_consent
hormonal 7 15 5054 5062 I-contraception_consent
birth 16 21 5063 5068 I-contraception_consent
control 22 29 5069 5076 I-contraception_consent
methods 30 37 5077 5084 I-contraception_consent
: 37 38 5084 5085 O
pills 39 44 5086 5091 B-contraception_consent
, 44 45 5091 5092 O
shots 46 51 5093 5098 B-contraception_consent
/ 51 52 5098 5099 I-contraception_consent
injections 52 62 5099 5109 I-contraception_consent
, 62 63 5109 5110 O
implants 64 72 5111 5119 B-contraception_consent
( 73 74 5120 5121 O
placed 74 80 5121 5127 O
under 81 86 5128 5133 O
the 87 90 5134 5137 O
skin 91 95 5138 5142 O
by 96 98 5143 5145 O
a 99 100 5146 5147 O
health 101 107 5148 5154 O
care 108 112 5155 5159 O
provider 113 121 5160 5168 O
) 121 122 5168 5169 O
, 122 123 5169 5170 O
or 124 126 5171 5173 O
patches 127 134 5174 5181 B-contraception_consent
( 135 136 5182 5183 O
placed 136 142 5183 5189 O
on 143 145 5190 5192 O
the 146 149 5193 5196 O
skin 150 154 5197 5201 O
) 154 155 5201 5202 O

Using 0 5 5203 5208 B-contraception_consent
2 6 7 5209 5210 I-contraception_consent
barrier 8 15 5211 5218 I-contraception_consent
methods 16 23 5219 5226 I-contraception_consent
( 24 25 5227 5228 I-contraception_consent
each 25 29 5228 5232 I-contraception_consent
partner 30 37 5233 5240 I-contraception_consent
must 38 42 5241 5245 I-contraception_consent
use 43 46 5246 5249 I-contraception_consent
1 47 48 5250 5251 I-contraception_consent
barrier 49 56 5252 5259 I-contraception_consent
method 57 63 5260 5266 I-contraception_consent
) 63 64 5266 5267 I-contraception_consent
with 65 69 5268 5272 I-contraception_consent
a 70 71 5273 5274 I-contraception_consent
spermicide 72 82 5275 5285 I-contraception_consent
; 82 83 5285 5286 O
males 84 89 5287 5292 B-gender
must 90 94 5293 5297 O
use 95 98 5298 5301 B-contraception_consent
the 99 102 5302 5305 I-contraception_consent
male 103 107 5306 5310 I-contraception_consent
condom 108 114 5311 5317 I-contraception_consent
( 115 116 5318 5319 I-contraception_consent
latex 116 121 5319 5324 I-contraception_consent
or 122 124 5325 5327 I-contraception_consent
other 125 130 5328 5333 I-contraception_consent
synthetic 131 140 5334 5343 I-contraception_consent
material 141 149 5344 5352 I-contraception_consent
) 149 150 5352 5353 I-contraception_consent
with 151 155 5354 5358 I-contraception_consent
spermicide 156 166 5359 5369 I-contraception_consent
; 166 167 5369 5370 O
females 168 175 5371 5378 B-gender
must 176 180 5379 5383 O
choose 181 187 5384 5390 B-contraception_consent
either 188 194 5391 5397 I-contraception_consent
a 195 196 5398 5399 I-contraception_consent
diaphragm 197 206 5400 5409 I-contraception_consent
with 207 211 5410 5414 I-contraception_consent
spermicide 212 222 5415 5425 I-contraception_consent
, 222 223 5425 5426 I-contraception_consent
or 224 226 5427 5429 I-contraception_consent
cervical 227 235 5430 5438 I-contraception_consent
cap 236 239 5439 5442 I-contraception_consent
with 240 244 5443 5447 I-contraception_consent
spermicide 245 255 5448 5458 I-contraception_consent
, 255 256 5458 5459 I-contraception_consent
or 257 259 5460 5462 I-contraception_consent
a 260 261 5463 5464 I-contraception_consent
sponge 262 268 5465 5471 I-contraception_consent
( 269 270 5472 5473 I-contraception_consent
spermicide 270 280 5473 5483 I-contraception_consent
is 281 283 5484 5486 I-contraception_consent
already 284 291 5487 5494 I-contraception_consent
in 292 294 5495 5497 I-contraception_consent
the 295 298 5498 5501 I-contraception_consent
contraceptive 299 312 5502 5515 I-contraception_consent
sponge 313 319 5516 5522 I-contraception_consent
) 319 320 5522 5523 I-contraception_consent

